Alpelisib-Piqray latest quotation inquiry channels and methods

Alpelisib (Alpelisib)-Piqray is marketed overseas under the trade name Piqray. It has not yet been officially sold in mainland China, so domestic hospitals or pharmacies cannot purchase it directly for the time being. For breast cancer patients who need to know the latest prices or purchasing channels, they can usually check through formal cross-border drug service platforms or overseas pharmacy official websites. According to overseas market conditions, the original drug of Apelvis is mainly produced by Novartis (Novartis) and is divided into two main versions: the European version and the Indian version.

The European versionDue to higher production standards and channel costs, Piqray's 150mg*56 tablet package usually sells for more than 40,000 yuan overseas. The Indian version is produced by a factory authorized by Novartis and is relatively affordable, with a 150mg*28 tablet package costing about 7,000 yuan. In addition to original drugs, generic drugs have been launched in Laos and other places. The common specifications are 150mg*28 tablets and the price is about 2,000 yuan. Generic drugs are basically the same as the original drugs in terms of chemical composition and bioequivalence, making them a realistic choice for many patients with greater financial pressure.

To obtain an accurate quote, it is recommended to go through the official website of an overseas pharmacy or a certified third-party drug inquiry platform. In addition, some domestic cross-border medical institutions can assist in checking real-time prices and legal purchase channels, but patients should be wary of informal drug purchases to avoid purchasing counterfeit drugs or inferior generic drugs.

It is worth mentioning that with the gradual liberalization of international drug circulation policies, Apelvis is expected to be approved for listing in China in the future. Relevant clinical studies are currently underway in China. Once approved, it will help reduce medication costs and standardize supply channels.

In general, to understand the latest quotation of Apelvis (Piqray), you should mainly rely on authoritative overseas pharmacy data and make a comprehensive judgment based on exchange rate changes.

Reference materials:https://www.piqray.com/